Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39402

DNM1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The DNM1 Knockout HEK293T Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population in which Dynamin 1, a GTPase critical for clathrin-mediated endocytosis and vesicle scission, is disrupted. This model utilizes HEK293T cells, a robust platform for protein expression and viral packaging, to explore membrane trafficking mechanisms. Dynamin 1 functions through interactions with amphiphysin and endophilin to mediate internalization of transferrin receptor and EGFR. DNM1 knockout enables analysis of endocytic pathway compensation, signaling defects, and dynamin isoform roles, supporting assays like transferrin uptake and live-cell imaging.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DNM1

    Gene Identifier

    NCBI Gene ID 1759

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNM1 Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the DNM1 gene has been disrupted to impair expression of Dynamin 1. This population provides a genetically heterogeneous loss-of-function model, enabling robust assessment of Dynamin 1-dependent processes without clonal selection artifacts. The polyclonal format facilitates the study of gene disruption effects across a range of editing outcomes, offering a versatile tool for functional genomics and endocytosis research in a widely used human cell background.

These cells are derived from the HEK293T host cell line, a female embryonic kidney epithelial derivative of HEK293 that stably expresses the SV40 large T-antigen. This immortalized line is renowned for its high transfectability, robust protein expression, and capacity for efficient viral packaging, making it a preferred system for studying membrane trafficking and signaling. The adherent epithelial morphology and rapid growth kinetics of HEK293T cells support high-throughput and imaging-based assays, ensuring compatibility with standard cell culture workflows.

Dynamin 1, encoded by DNM1, is a large GTPase essential for membrane fission during clathrin-mediated endocytosis and synaptic vesicle recycling. It assembles into helical polymers at the necks of budding clathrin-coated vesicles, where GTP hydrolysis drives constriction and scission. Dynamin 1 function is regulated by interactions with amphiphysin, endophilin, and syndapin, and is modulated by AP-2 complex, calcium signaling, and Src-family kinases. Downstream, Dynamin 1 acts on clathrin-coated vesicles to internalize cargo such as transferrin receptor and epidermal growth factor receptor (EGFR), directly linking receptor-mediated uptake to intracellular signaling cascades. Additional interacting partners like Grb2, cortactin, and SNX9 fine-tune Dynamin 1 localization and activity at distinct endocytic sites.

Although DNM1 is predominantly associated with neuronal functions, its fundamental role in clathrin-mediated endocytosis is conserved across cell types. In HEK293T cells, Dynamin 1 contributes to constitutive and growth factor?Cinduced endocytosis, and its knockout reveals functional compensation by the ubiquitously expressed dynamin isoforms DNM2 and DNM3. This model is therefore valuable for dissecting isoform-specific roles in membrane trafficking and for identifying pathway components that become rate-limiting upon loss of Dynamin 1. The knockout cells offer a genetically defined platform to explore how endocytic defects impact signaling downstream of EGFR and transferrin receptor, with relevance to neurodevelopmental disorders linked to DNM1 mutations.

Researchers can employ this polyclonal knockout model in an array of functional assays, including transferrin uptake assays to quantify clathrin-mediated endocytosis, Western blotting and immunofluorescence to assess Dynamin 1 depletion and vesicle marker distribution, and live-cell imaging to monitor vesicle dynamics. The cells are suitable for GTPase activity measurements and electron microscopy studies of clathrin-coated pit morphology, as well as for drug discovery screens targeting dynamin-related pathways. This product thus supports mechanistic investigations into membrane trafficking, receptor signaling, and the cellular consequences of DNM1 loss. For further information or to discuss your specific research needs, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)